Programmed Death-Ligand 1–Rich Premetastatic Niche in Adjuvant Chemotherapy

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.10.019 ◽

2022 ◽

Vol 17 (1) ◽

pp. 10-12

Author(s):

Hiromasa Yamamoto ◽

Yosuke Togashi

Keyword(s):

Adjuvant Chemotherapy ◽

Programmed Death Ligand 1 ◽

Premetastatic Niche ◽

Programmed Death

Download Full-text

Influence of Programmed Death Ligand-1-Gene Polymorphism rs822336 on the Prognosis and Safety of Postoperative Patients with NSCLC Who Received Platinum-Based Adjuvant Chemotherapy

Cancer Management and Research ◽

10.2147/cmar.s255072 ◽

2020 ◽

Vol Volume 12 ◽

pp. 6755-6766

Author(s):

Ming Zhao ◽

Jing Zhang ◽

Siyu Chen ◽

Yuqi Wang ◽

Qing Tian

Keyword(s):

Adjuvant Chemotherapy ◽

Gene Polymorphism ◽

Programmed Death Ligand 1 ◽

Programmed Death

Download Full-text

P3.02c-082 Altered Expression of Programmed Death-Ligand 1 after Neo-Adjuvant Chemotherapy in Patients with Lung Squamous Cell Carcinoma

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2016.11.1878 ◽

2017 ◽

Vol 12 (1) ◽

pp. S1327-S1328

Author(s):

Zhengbo Song ◽

Yiping Zhang ◽

Xinmin Yu

Keyword(s):

Squamous Cell Carcinoma ◽

Adjuvant Chemotherapy ◽

Cell Carcinoma ◽

Squamous Cell ◽

Lung Squamous Cell Carcinoma ◽

Altered Expression ◽

Programmed Death Ligand 1 ◽

Programmed Death ◽

Neo Adjuvant Chemotherapy

Download Full-text

Adjuvant Chemotherapy Increases Programmed Death-Ligand 1 (PD-L1) Expression in Non–small Cell Lung Cancer Recurrence

Clinical Lung Cancer ◽

10.1016/j.cllc.2019.05.013 ◽

2019 ◽

Vol 20 (5) ◽

pp. 391-396 ◽

Author(s):

Max Lacour ◽

Stefanie Hiltbrunner ◽

Seok-Yun Lee ◽

Alex Soltermann ◽

Elisabeth Jane Rushing ◽

...

Keyword(s):

Lung Cancer ◽

Adjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Cancer Recurrence ◽

Small Cell Lung ◽

Programmed Death Ligand 1 ◽

Programmed Death

Download Full-text

JCES01.11 Altered Expression of Programmed Death-Ligand 1 after Neo-Adjuvant Chemotherapy in Patients with Lung Squamous Cell Carcinoma

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2016.11.213 ◽

2017 ◽

Vol 12 (1) ◽

pp. S234-S235

Author(s):

Zhengbo Song ◽

Yiping Zhang ◽

Xinmin Yu

Keyword(s):

Squamous Cell Carcinoma ◽

Adjuvant Chemotherapy ◽

Cell Carcinoma ◽

Squamous Cell ◽

Lung Squamous Cell Carcinoma ◽

Altered Expression ◽

Programmed Death Ligand 1 ◽

Programmed Death ◽

Neo Adjuvant Chemotherapy

Download Full-text

Altered expression of programmed death-ligand 1 after neo-adjuvant chemotherapy in patients with lung squamous cell carcinoma

Lung Cancer ◽

10.1016/j.lungcan.2016.07.013 ◽

2016 ◽

Vol 99 ◽

pp. 166-171 ◽

Author(s):

Zhengbo Song ◽

Xinmin Yu ◽

Yiping Zhang

Keyword(s):

Squamous Cell Carcinoma ◽

Adjuvant Chemotherapy ◽

Cell Carcinoma ◽

Squamous Cell ◽

Lung Squamous Cell Carcinoma ◽

Altered Expression ◽

Programmed Death Ligand 1 ◽

Programmed Death ◽

Neo Adjuvant Chemotherapy

Download Full-text

Prognostic Value of Programmed Death Ligand-1 Expression on Tumor-Infiltrating Immune Cells in Patients Treated with Cisplatin-Based Combination Adjuvant Chemotherapy Following Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective Cohort Study

OncoTargets and Therapy ◽

10.2147/ott.s291327 ◽

2021 ◽

Vol Volume 14 ◽

pp. 845-855

Author(s):

Dong Hyeon Lee ◽

Jae Yong Jeong ◽

Wan Song

Keyword(s):

Bladder Cancer ◽

Cohort Study ◽

Adjuvant Chemotherapy ◽

Immune Cells ◽

Retrospective Cohort ◽

Prognostic Value ◽

Muscle Invasive Bladder Cancer ◽

Programmed Death Ligand 1 ◽

Programmed Death ◽

Muscle Invasive

Download Full-text

Author response for "Plasma soluble programmed death ligand 1 levels predict clinical response in peripheral T‐cell lymphomas"

10.1002/hon.2636/v2/response1 ◽

2019 ◽

Author(s):

Lu Liu ◽

Shiyong Zhou ◽

Kuo Zhao ◽

Zheng Song ◽

Ge Hu ◽

...

Keyword(s):

T Cell ◽

Clinical Response ◽

Author Response ◽

Programmed Death Ligand 1 ◽

T Cell Lymphomas ◽

Programmed Death ◽

Peripheral T Cell Lymphomas

Download Full-text

Decision letter for "Plasma soluble programmed death ligand 1 levels predict clinical response in peripheral T‐cell lymphomas"

10.1002/hon.2636/v1/decision1 ◽

2019 ◽

Keyword(s):

T Cell ◽

Clinical Response ◽

Programmed Death Ligand 1 ◽

T Cell Lymphomas ◽

Programmed Death ◽

Peripheral T Cell Lymphomas

Download Full-text

226 Programmed Death - Ligand 1 Inhibitors: A Safer Immune Checkpoint Inhibitor for the Kidneys

American Journal of Kidney Diseases ◽

10.1053/j.ajkd.2019.03.228 ◽

2019 ◽

Vol 73 (5) ◽

pp. 701

Keyword(s):

Immune Checkpoint ◽

Immune Checkpoint Inhibitor ◽

Checkpoint Inhibitor ◽

Programmed Death Ligand 1 ◽

Programmed Death

Download Full-text

PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN UTERINE GRADE 3 ENDOMETRIOID ADENOCANCER

10.26226/morressier.597eedbed462b80296ca1075 ◽

2017 ◽

Author(s):

Kucukgoz Gulec Umran

Keyword(s):

Programmed Death Ligand 1 ◽

Programmed Death ◽

Programmed Death 1 ◽

Download Full-text